October 23, 2014 11:13 AM ET


Company Overview of Abraxis Oncology, Inc.

Executive Profile

Dvorit Samid Ph.D.

Vice President of Medical Affairs, Synta Pharmaceuticals Corp.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 3 different industries.



Dr. Dvorit Samid, Ph.D. has been Vice President of Medical Affairs at Synta Pharmaceuticals Corp., since March 12, 2012. Dr. Samid served as a Vice President, Medical Affairs of Imclone Systems Inc. from August 1, 2005 to 2009. Dr. Samid served as Executive Director of Medical Affairs of ABRAXIS Oncology, American Pharmaceutical Partners Inc.'s proprietary pharmaceutical division, since December 15, 2003. Dr. Samid has three decades of oncology research and drug development ...

Corporate Headquarters

200 Somerset Corporate Boulevard
Bridgewater, New Jersey 08807

United States

Phone: 908-393-8220
Fax: 908-393-8250

Board Members Memberships



Bachelor's Degree
Hebrew University of Jerusalem
Catholic University of America

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Abraxis Oncology, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.